BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area?

E-ISSN： 1529-8019|29|3|168-172

ISSN： 1396-0296

Source： DERMATOLOGIC THERAPY, Vol.29, Iss.3, 2016-05, pp. : 168-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature

DERMATOLOGIC THERAPY, Vol. 29, Iss. 3, 2016-05 ,pp. : 197-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors contributing to the treatment duration of diphenylcyclopropenone immunotherapy for periungual warts

DERMATOLOGIC THERAPY, Vol. 29, Iss. 2, 2016-03 ,pp. : 114-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study

DERMATOLOGIC THERAPY, Vol. 28, Iss. 4, 2015-07 ,pp. : 194-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Topical malic acid in combination with citric acid: an option to treat recalcitrant warts

DERMATOLOGIC THERAPY, Vol. 28, Iss. 6, 2015-11 ,pp. : 336-338

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of squaric acid dibutyl ester in treatment of recalcitrant warts in children

DERMATOLOGIC THERAPY, Vol. 28, Iss. 5, 2015-09 ,pp. : 330-330

John Wiley & Sons Inc

Access to resources Recommend Favorite